Le mode conseil est activé Arrêter

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout
 
(%)
IE00BYXG2H39
BTEC ISIN
Fonds négociés en bourse (FNB)
Type de fonds
BlackRock
Fournisseur
9,68 USD
valeur liquidative par action | 10/07/2026
19/10/2017
Date de lancement
Non
Paiement de dividendes
CEOGMS
CFI
BTEC
Ticker
Formed
Status
Equity
Objet d'investissement
Biotech
Secteur
USA
Géographie
Nasdaq Biotechnology Index
Benchmark
0.35 %
Ratio de coût total
1.168,7 mln USD
Actif total du fonds | 10/07/2026
1.095,37 mln USD
Volume des actits de classe "actions" | 10/07/2026
Oui
UCITS

Dernières données pour
Ajouter à comparer
de
au
ADD-IN
Add-in Cbonds API
bond data api

Cotations (BTEC)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

175 910

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN
Obtenir l'accès

Dynamique des prix

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Structure BTEC au 10/07/2026

Exporter la structure dans Excel
Titre Valeur
VERTEX PHARMACEUTICALS INC 7,85%
AMGEN INC 7,81%
GILEAD SCIENCES INC 6,99%
REGENERON PHARMACEUTICALS INC 4,72%
ALNYLAM PHARMACEUTICALS INC 2,75%
REVOLUTION MEDICINES INC 2,74%
BIOGEN INC 2,03%
ILLUMINA INC 1,99%
MODERNA INC 1,87%
ROIVANT SCIENCES LTD 1,78%
INSMED INC 1,73%
ROYALTY PHARMA PLC CLASS A 1,73%
ARGENX SE ADR 1,67%
INCYTE CORP 1,61%
UNITED THERAPEUTICS CORP 1,6%
GUARDANT HEALTH INC 1,46%
VIATRIS INC 1,31%
NEUROCRINE BIOSCIENCES INC 1,23%
BRIDGEBIO PHARMA INC 1,16%
ASCENDIS PHARMA 1,15%
MEDPACE HOLDINGS INC 1,06%
JAZZ PHARMACEUTICALS PLC 1,06%
EXELIXIS INC 0,98%
MADRIGAL PHARMACEUTICALS INC 0,86%
AXSOME THERAPEUTICS INC 0,83%
SUMMIT THERAPEUTICS INC 0,82%
CYTOKINETICS INC 0,8%
BIOMARIN PHARMACEUTICAL INC 0,79%
KRYSTAL BIOTECH INC 0,75%
ARROWHEAD PHARMACEUTICALS INC 0,74%
BIONTECH SE ADR 0,74%
TEMPUS AI INC CLASS A 0,7%
SANOFI ADR REPRESENTING SA 0,7%
KYMERA THERAPEUTICS INC 0,68%
BEONE MEDICINES AG 0,68%
IONIS PHARMACEUTICALS INC 0,67%
HALOZYME THERAPEUTICS INC 0,63%
NUVALENT INC CLASS A 0,63%
PRAXIS PRECISION MEDICINES INC 0,62%
CRINETICS PHARMACEUTICALS INC 0,61%
ALKERMES 0,59%
IMMUNITYBIO INC 0,59%
SPYRE THERAPEUTICS INC 0,58%
PROTAGONIST THERAPEUTICS INC 0,58%
VAXCYTE INC 0,58%
APOGEE THERAPEUTICS INC 0,57%
IMMUNOVANT INC 0,57%
ABIVAX AMERICAN DEPOSITARY SHARES 0,56%
MIRUM PHARMACEUTICALS INC 0,51%
RHYTHM PHARMACEUTICALS INC 0,51%
PTC THERAPEUTICS INC 0,48%
SCHOLAR ROCK HOLDING CORP 0,47%
COGENT BIOSCIENCES INC 0,46%
XENON PHARMACEUTICALS INC 0,46%
CG ONCOLOGY INC 0,46%
LIGAND PHARMACEUTICALS INC 0,43%
ERASCA INC 0,4%
TWIST BIOSCIENCE CORP 0,39%
AMNEAL PHARMACEUTICALS INC CLASS A 0,37%
TRAVERE THERAPEUTICS INC 0,36%
ORUKA THERAPEUTICS INC 0,36%
CRISPR THERAPEUTICS AG 0,35%
DEFINIUM THERAPEUTICS INC 0,35%
10X GENOMICS INC CLASS A 0,34%
INDIVIOR PHARMACEUTICALS INC 0,34%
EDGEWISE THERAPEUTICS INC 0,34%
CARIS LIFE SCIENCES INC 0,33%
VERACYTE INC 0,31%
TANGO THERAPEUTICS INC 0,31%
ACADIA PHARMACEUTICALS INC 0,31%
RELAY THERAPEUTICS INC 0,29%
STRUCTURE THERAPEUTICS ADR INC 0,29%
NEWAMSTERDAM PHARMA NV 0,28%
DENALI THERAPEUTICS INC 0,28%
DYNE THERAPEUTICS INC 0,27%
ALUMIS INC 0,24%
ARCUTIS BIOTHERAPEUTICS INC 0,24%
ADAPTIVE BIOTECHNOLOGIES CORP 0,24%
BEAM THERAPEUTICS INC 0,23%
ULTRAGENYX PHARMACEUTICAL INC 0,23%
IDEAYA BIOSCIENCES INC 0,22%
ENLIVEN THERAPEUTICS INC 0,21%
GRAIL INC 0,21%
VERA THERAPEUTICS INC CLASS A 0,21%
KINIKSA PHARMACEUTICALS INTERNATIO 0,2%
DISC MEDICINE INC 0,2%
MBX BIOSCIENCES INC 0,2%
SUPERNUS PHARMACEUTICALS INC 0,19%
UNIQURE NV 0,19%
BIOCRYST PHARMACEUTICALS INC 0,18%
KODIAK SCIENCES INC 0,18%
TREVI THERAPEUTICS INC 0,17%
TARSUS PHARMACEUTICALS INC 0,17%
AGIOS PHARMACEUTICALS INC 0,17%
PHARVARIS N V NV 0,17%
VERICEL CORP 0,17%
NURIX THERAPEUTICS INC 0,17%
MINERALYS THERAPEUTICS INC 0,16%
LEGEND BIOTECH ADR REP CORP 0,16%
OCULAR THERAPEUTIX INC 0,16%
Montrer tout Cacher
Autres - %

Autres actions de ce fonds

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Montrer tout

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.